Haleon (HLN) Cash from Investing Activities (2021 - 2025)
Haleon's (HLN) quarterly Cash from Investing Activities came in at -$101.8 million in Q4 2025, up 56.36% on a QoQ basis from -$233.3 million in Q4 2023.
Haleon (HLN) Cash from Investing Activities (2021 - 2025) Analysis & Trends
Haleon (HLN) has 4 years of Cash from Investing Activities data on file, last reported at -$101.8 million in Q4 2025.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$101.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$21.0 billion (changed N/A YoY) and the FY2025 annual result came in at -$460.2 million, down 168.19% from the prior year.
- Cash from Investing Activities rose to -$101.8 million in Q4 2025, from -$233.3 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $624.1 million in Q4 2021 to a low of -$10.6 billion in Q3 2022.
- A 4-year average of -$4.1 billion and a median of -$233.3 million in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 1713.76% — and 2023, when it jumped 97.68%.
- Tracing HLN's Cash from Investing Activities over 4 years: stood at $624.1 million in 2021, then tumbled by 1713.76% to -$10.1 billion in 2022, then jumped by 97.68% to -$233.3 million in 2023, then soared by 56.36% to -$101.8 million in 2025.
- The last three Cash from Investing Activities figures came in at -$101.8 million (Q4 2025), -$233.3 million (Q4 2023), and -$10.1 billion (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.65 Bn | 29.97 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.89 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.12 Bn | 11.59 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.23 Bn | 7.57 Bn | 397.90 Mn | -2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -101.83 Mn |
| Dec 31, 2025 | -101.83 Mn |
| Dec 31, 2023 | -233.34 Mn |
| Dec 31, 2023 | -233.34 Mn |
| Dec 31, 2022 | -10.07 Bn |
| Dec 31, 2022 | -10.07 Bn |
| Sep 20, 2022 | -10.57 Bn |
| Sep 20, 2022 | -10.57 Bn |
| Dec 31, 2021 | 624.13 Mn |
| Dec 31, 2021 | 624.13 Mn |